Correlation Between ELYM Old and Ascletis Pharma
Can any of the company-specific risk be diversified away by investing in both ELYM Old and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ELYM Old and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ELYM Old and Ascletis Pharma, you can compare the effects of market volatilities on ELYM Old and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ELYM Old with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ELYM Old and Ascletis Pharma.
Diversification Opportunities for ELYM Old and Ascletis Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ELYM and Ascletis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ELYM Old and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and ELYM Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ELYM Old are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of ELYM Old i.e., ELYM Old and Ascletis Pharma go up and down completely randomly.
Pair Corralation between ELYM Old and Ascletis Pharma
If you would invest 24.00 in Ascletis Pharma on December 26, 2024 and sell it today you would earn a total of 96.00 from holding Ascletis Pharma or generate 400.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ELYM Old vs. Ascletis Pharma
Performance |
Timeline |
ELYM Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Ascletis Pharma |
ELYM Old and Ascletis Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ELYM Old and Ascletis Pharma
The main advantage of trading using opposite ELYM Old and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ELYM Old position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.The idea behind ELYM Old and Ascletis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |